No Smoking! Startup's Tiny Answer To Safer Medical Cannabis - NoCamels
IMCI Pharmaceuticals, an Israeli startup, has developed a method to create nanoparticles from cannabis for more effective medical delivery, reducing the need for smoking. The company's iCann platform offers three products: a fast-acting sublingual pill, a long-lasting oral tablet, and a swallowed pill, all designed for chronic ailments. IMCI plans to conduct human trials in Jerusalem next year and aims to bring its first product to market within a year.
Reference News
IMCI Pharmaceuticals, an Israeli startup, has developed a method to create nanoparticles from cannabis for more effective medical delivery, reducing the need for smoking. The company's iCann platform offers three products: a fast-acting sublingual pill, a long-lasting oral tablet, and a swallowed pill, all designed for chronic ailments. IMCI plans to conduct human trials in Jerusalem next year and aims to bring its first product to market within a year.